• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.

Combined anticancer effects of sphingosine kinase inhibitors and sorafenib. Invest New Drugs. 2011 Dec; 29(6):1132-42.

View in: PubMed

subject areas
  • Adamantane
  • Adenocarcinoma
  • Administration, Oral
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols
  • Benzenesulfonates
  • Caspase 3
  • Caspase 7
  • Catechols
  • Cell Line, Tumor
  • DNA Fragmentation
  • Drug Synergism
  • Female
  • Humans
  • Kidney Neoplasms
  • Mice
  • Mice, SCID
  • Niacinamide
  • Pancreatic Neoplasms
  • Phenylurea Compounds
  • Phosphotransferases (Alcohol Group Acceptor)
  • Pyridines
  • Xenograft Model Antitumor Assays

authors with profiles
  • Charles D. Smith